Physician profile
Vivek Nagar
NPI 1689104960
$8,147.99
in general payments reported to CMS, 2019-2025
12 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $36.28 · 2022: $5,293 · 2023: $1,299 · 2024: $23.08 · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,772 · Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,772.27 |
| Food and Beverage | $739.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,768.42 | 2022 | |
| Boston Scientific Corporation | $1,233.82 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $775.48 | 2023 | Intracept |
| Stryker Corporation | $588.58 | 2023-2025 | Spinejack, Mild Device Kit |
| Medtronic, INC. | $214.56 | 2022 | |
| Merz North America, INC. | $199.59 | 2019-2020 | |
| Allergan, INC. | $143.80 | 2019 | |
| Nevro Corp. | $93.12 | 2022-2023 | Senza |
| Spr Therapeutics, INC | $52.00 | 2022 | |
| Averitas Pharma INC. | $41.20 | 2023-2024 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $20.88 | 2022 | |
| Nalu Medical, INC. | $16.54 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Nagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.